多杀性巴氏杆菌
支气管败血症博德特菌
鼻腔给药
接种疫苗
医学
抗体
生物
佐剂
兽医学
病毒学
免疫学
细菌
遗传学
作者
H.‐J. Riising,Paul van Empel,M. H. Witvliet
标识
DOI:10.1136/vr.150.18.569
摘要
The efficacy of a new vaccine against atrophic rhinitis in pigs was tested in the Netherlands and Denmark. The vaccine contained protein dO (a truncated Pasteurella multocida toxin which is immunogenic and non-toxic), inactivated Bordetella bronchiseptica whole cells, and an adjuvant. The sows were either vaccinated intramuscularly with 2 ml of the vaccine at six to eight and two to four weeks before expected farrowing or left unvaccinated as controls. All the piglets were challenged intranasally with B bronchiseptica when three to seven days old and with P multocida three to four days later. Pigs born to the vaccinated sows performed significantly better than pigs born to the control sows when judged on growth, average daily weight gain and snout scores. The challenge organisms were reisolated more frequently from the control pigs than from the pigs in the vaccinated group. The vaccinated sows and their progeny developed high titres of antibodies against B bronchiseptica and P multocida toxin.
科研通智能强力驱动
Strongly Powered by AbleSci AI